The Prostate Cancer Foundation posted two useful and basic articles on its blog site this December that may be useful resources for men concerned about their risk for or newly diagnosed with prostate cancer or monitoring their PSA over time (for any one of all sorts of possible reasons). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: accuracy, advice, diagnosed, guidance, newly, PSA, test | 4 Comments »
As many readers will be aware, the U.S. Preventive Services Task Force (USPSTF) recently issued new, draft guidance on the role of testing for risk of prostate cancer, and most particularly on the use of PSA testing in men of 55 years and older. All public comment on the proposed new draft recommendations is due on or before May 8 upcoming. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidance, recommendation, screening, testing, USPSTF | 8 Comments »
ASCO has just released a new set of provisional guidance (a “provisional clinical opinion” or PCO) on the second-line treatment of men with chemotherapy-naive, castration-resistant prostate cancer (CRPC), i.e., men who are progressing on initial androgen deprivation therapy (ADT or “hormone” therapy) but who haven’t had docetaxel-based chemotherapy yet. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ASCO, castration-resistant, chemotherapy-naïve, CRPC, guidance | 4 Comments »
As indicated earlier this morning, the US Preventive Services Task Force (USPSTF) has issued new draft guidance on screening for risk of prostate cancer. Access to all the relevant details is provided below: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidance, PSA, screening, testing, USPSTF | 17 Comments »
As our regular readers will be well aware, the combination of multiparametric MRI (mpMRI) data with transrectal ultrasound (TRUS)-guided biopsy techniques are rapidly becoming more common in both the diagnosis of prostate cancer and in monitoring risk for prostate cancer in men on active surveillance protocols. … READ MORE …
Filed under: Diagnosis, Management | Tagged: biopsy, guidance, MRI, MRI/TRUS fusuon | 11 Comments »
Yesterday the American Urology Association (AUA) issued a second set of five recommendations to its members through the Choosing Wisely initiative (which is coordinated by the ABIM Foundation). Two of these recommendations were specific to risk for prostate cancer and its management. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, guidance, prostate, PSA, recommendation | Leave a comment »
Three weeks ago we mentioned a new six-point statement about PSA screening developed at a meeting in Melbourne, Australia. We would note that an updated set of information about this statement is now available on the BJU International web site. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: concensus, guidance, PSA, screening, statement, testing | Leave a comment »
As many readers will be aware, there have been two new sets of guidance about screening for prostate cancer issued in the past few months — the most recent from the American Urological Association just a couple of weeks ago. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: guidance, PSA, screening | 5 Comments »
Image-guided methods for targeting radiation therapy (IGRT) are crucial in the treatment of localized prostate cancer. ASTRO has now issued the final version of a new white paper addressing “best practices” to improve the safety and effectiveness of these types of technology in clinical practice. … READ MORE …
Filed under: Management, Treatment | Tagged: guidance, IGRT, image, radiation | 3 Comments »
According to a new article in the journal Nutrition and Cancer, “Consistent online dietary recommendations are lacking for patients during and after cancer treatment.” This will hardly come as a shock to many in the prostate cancer community, but an article like this one may help to initiate development of better guidelines. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: guidance, guidelines, nutrition | 3 Comments »
Prostate cancer patients who are to be treated with any type of intensity-modulated radiation therapy (IMRT) for localized prostate cancer today can be pardoned if they are confused by the many ways in which that radiation therapy can be aimed and targeted through the use of image guidance (IGRT) systems. The variety of methods is significant and growing. … READ MORE …
Filed under: Management, Treatment | Tagged: guidance, IGRT, image, IMRT, intensity-modulated, radiation, therapy | 3 Comments »
In the UK, the National Institute for Clinical Excellence (NICE) has just published guidance on the use of focal forms of high-intensity focused ultrasound (HIFU) for the treatment of (low- and intermediate-risk forms of) localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: focal, guidance, HIFU, high-intensity focused ultrasound, NICE | 5 Comments »
A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, color Döppler, Diagnosis, guidance, SonoVue, transrectal, ultrasound | 4 Comments »
The American Urological Association (AUA) has written to the U.S. Food & Drug Administration (FDA) seeking modification of the FDA’s recent guidance on the use of 5α-reductase inhibitors like dutasteride and finasteride in the management of urologic conditions. … READ MORE …
Filed under: Management, Prevention, Treatment | Tagged: 5-ARI, dutasteride, FDA, finasterine, guidance, safety | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 